Therapeutic potential of natural compounds for treatment of chronic obstructive pulmonary disease: Current status and future perspective

被引:1
|
作者
Sahu, Sanjeev Kumar [1 ]
Rain, Musarraf [1 ]
Vyas, Manish [1 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Jalandhar 144411, Punjab, India
关键词
Chronic obstructive pulmonary disease; Oxidative stress; Reactive oxygen species; Genetic factors; Alpha-1 antitrypsin deficiency; Mitochondria dysfunction; Natural compounds; CIGARETTE-SMOKE; INFLAMMATION; EXTRACT; PATHOGENESIS; EMPHYSEMA;
D O I
10.1016/j.ejmcr.2024.100159
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a lung disease which is the third most common cause of premature death globally. Inhaling dangerous gases, cigarette smoking, and exposure to pollution are the main factors contributing to the development of COPD. These factors may harm lung tissue and create COPD causes. Increased synthesis of inflammatory mediators and proteases because of cigarette smoking exposure to transcriptional factors. Dysfunction of mitochondria essential part to lead and development of several human illnesses, such as chronic obstructive pulmonary disease. Alpha-1 antitrypsin deficiency boosts neutrophil elastase activity, which promotes tissue deterioration and emphysema (particularly in smokers because cigarette smoke also boosts protease activity). In this review, we discussed all these factors and summarized the conventional drug currently present for the treatment of COPD. In addition, we also focused on various natural compounds categorized under the flavonoids, polyphenols, alkaloids, glycosides and marine compounds which were reported for the effective treatment of COPD.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview
    Li, Liu-Ying
    Zhang, Chuan-Tao
    Zhu, Feng-Ya
    Zheng, Gang
    Liu, Yu-Fei
    Liu, Ke
    Zhang, Chen-Hui
    Zhang, Hong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Current status and inspiration on macrolides in the treatment of chronic obstructive pulmonary disease
    Qiu, Shi-lin
    Zhong, Xiao-ning
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2015, 3 (03) : 85 - 88
  • [3] The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives
    Ambrosino, Nicolino
    Paggiaro, Pierluigi
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (01) : 117 - 127
  • [4] Bronchodilating Drugs for Chronic Obstructive Pulmonary Disease: Current Status and Future Trends
    Montuschi, Paolo
    Ciabattoni, Giovanni
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (10) : 4131 - 4164
  • [5] Current treatment in chronic obstructive pulmonary disease
    李嘉惠
    中国新药与临床杂志, 2008, 27 (12) : 940 - 940
  • [6] Current treatment of chronic obstructive pulmonary disease
    Pomares, Xavier
    Monton, Concepcion
    MEDICINA CLINICA, 2016, 147 (01): : 28 - 34
  • [7] Current status and progress of prevention and treatment of chronic obstructive pulmonary disease in China
    LI Wei
    YANG Ting
    WANG Chen
    中国研究型医院, 2020, 7 (05) : 78 - 84
  • [8] Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease
    Shergis, J. L.
    Di, Y. M.
    Zhang, A. L.
    Vlahos, R.
    Helliwell, R.
    Ye, J. M.
    Xue, C. C.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2014, 22 (05) : 944 - 953
  • [9] Prophylactic vaccinations in chronic obstructive pulmonary disease: current status
    Varkey, Jay B.
    Varkey, Anita B.
    Varkey, Basil
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (02) : 90 - 99
  • [10] Search for biomarkers in chronic obstructive pulmonary disease: current status
    Nicholas, Benjamin L.
    CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (02) : 103 - 108